BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8953097)

  • 1. Possible development of resistance to fluconazole during suppressive therapy for AIDS-associated cryptococcal meningitis.
    Armengou A; Porcar C; Mascaró J; García-Bragado F
    Clin Infect Dis; 1996 Dec; 23(6):1337-8. PubMed ID: 8953097
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluconazole-resistant Cryptococcus neoformans var gattii in an AIDS patient.
    Peetermans W; Bobbaers H; Verhaegen J; Vandepitte J
    Acta Clin Belg; 1993; 48(6):405-9. PubMed ID: 8128821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluconazole penetration into the prostatic fluid of patients with AIDS-associated cryptococcal meningitis.
    Luzzati R; Gatti G; Lazzarini L; Limonta D; Vento S; Concia E
    J Antimicrob Chemother; 1998 Mar; 41(3):423-4. PubMed ID: 9578176
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
    Friese G; Discher T; Füssle R; Schmalreck A; Lohmeyer J
    AIDS; 2001 Nov; 15(17):2344-5. PubMed ID: 11698718
    [No Abstract]   [Full Text] [Related]  

  • 5. Cryptococcal meningitis in AIDS.
    Iyer RS; Banker DD
    Indian J Med Sci; 2002 Dec; 56(12):593-7. PubMed ID: 14514241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory features of cryptococcal meningitis in HIV-AIDS patients.
    Deo S
    J Assoc Physicians India; 1995 Oct; 43(10):724. PubMed ID: 8773019
    [No Abstract]   [Full Text] [Related]  

  • 7. Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole.
    Casadevall A; Spitzer ED; Webb D; Rinaldi MG
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1383-6. PubMed ID: 8328793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing.
    Witt MD; Lewis RJ; Larsen RA; Milefchik EN; Leal MA; Haubrich RH; Richie JA; Edwards JE; Ghannoum MA
    Clin Infect Dis; 1996 Feb; 22(2):322-8. PubMed ID: 8838190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of secondary resistance to fluconazole in Cryptococcus neoformans isolated from a patient with AIDS.
    Alves SH; Lopes JO; Costa JM; Klock C
    Rev Inst Med Trop Sao Paulo; 1997; 39(6):359-61. PubMed ID: 9674289
    [No Abstract]   [Full Text] [Related]  

  • 10. Cryptoccocal meningitis in Yaoundé (Cameroon) HIV infected patients: Diagnosis, frequency and Cryptococcus neoformans isolates susceptibility study to fluconazole.
    Kammalac Ngouana T; Dongtsa J; Kouanfack C; Tonfack C; Fomena S; Mallié M; Delaporte E; Boyom FF; Bertout S
    J Mycol Med; 2015 Mar; 25(1):11-6. PubMed ID: 25467817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden of cryptococcal meningitis in Malawi.
    Makombe SD; Nkhata A; Schouten EJ; Kamoto K; Harries AD
    Trop Doct; 2009 Jan; 39(1):32-4. PubMed ID: 19211421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis.
    Powderly WG; Cloud GA; Dismukes WE; Saag MS
    Clin Infect Dis; 1994 May; 18(5):789-92. PubMed ID: 8075272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current approach to the acute management of cryptococcal infections.
    Powderly WG
    J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.
    Lofgren S; Abassi M; Rhein J; Boulware DR
    Expert Rev Anti Infect Ther; 2017 Apr; 15(4):331-340. PubMed ID: 28111998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species.
    Bongomin F; Oladele RO; Gago S; Moore CB; Richardson MD
    Mycoses; 2018 May; 61(5):290-297. PubMed ID: 29377368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cryptococcal meningoencephalitis related to HIV infection with resistance to fluconazole, relapse, and IRIS].
    Seilmaier M; Hecht A; Guggemos W; Rüdisser K
    Med Klin (Munich); 2009 Jan; 104(1):58-62. PubMed ID: 19142596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of cryptococcal meningitis.
    Zingman BS
    N Engl J Med; 1997 Nov; 337(21):1557; author reply 1557-8. PubMed ID: 9380128
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-dose fluconazole as primary prophylaxis for cryptococcal infection in AIDS patients with CD4 cell counts of < or = 100/mm3: demonstration of efficacy in a positive, multicenter trial.
    Singh N; Barnish MJ; Berman S; Bender B; Wagener MM; Rinaldi MG; Yu VL
    Clin Infect Dis; 1996 Dec; 23(6):1282-6. PubMed ID: 8953072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro-clinical correlations for amphotericin B susceptibility in AIDS-associated cryptococcal meningitis.
    Larsen RA; Bauer M; Brouwer AE; Sanchez A; Thomas AM; Rajanuwong A; Chierakul W; Peacock SJ; Day N; White NJ; Rinaldi MG; Harrison TS
    Antimicrob Agents Chemother; 2007 Jan; 51(1):343-5. PubMed ID: 17060519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cryptococcus neoformans meningitis in patients with AIDS at the Saint Thomas Hospital].
    Sierra LO; Suárez M; Rodríguez French A
    Rev Med Panama; 1996; 21(1-2):46-50. PubMed ID: 8966238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.